TuHURA Biosciences
HURA
3 hedge funds and large institutions have $4.28M invested in TuHURA Biosciences in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
584% more capital invested
Capital invested by funds: $626K → $4.28M (+$3.66M)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$2.78M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Franklin Resources
San Mateo,
California
| $2.48M | +$2.78M | +62 | New |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $1.48M | +$1.66M | +37 | New |
|
|
RJFSA
3
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $294K | – | – | – |
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| $20K | – | – | – |
|
5
UBS Group
Zurich,
Switzerland
| $7K | – | – | – |
|
|
6
Goldman Sachs
New York
| – | -$46K | -1 | Closed |
|
HURA Hedge Fund Activity: Q2 2017 in Review
3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2017, worth a combined $4.28M — up 584% from $626K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new HURA positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $2.78M. The largest seller was Goldman Sachs, exiting entirely with an estimated $46K sold.
- 3 institutional investors held TuHURA Biosciences (HURA) as of Q2 2017, up from 2 in Q1 2017.
- Funds reported $4.28M of TuHURA Biosciences stock for Q2 2017, up 584% quarter-over-quarter.
- 2 funds opened new TuHURA Biosciences positions in Q2 2017 and 1 closed out, a net change of +1 holder.
- The largest TuHURA Biosciences buyer in Q2 2017 was Franklin Resources, an estimated $2.78M added.
- The largest TuHURA Biosciences seller in Q2 2017 was Goldman Sachs, an estimated $46K sold.
Based on aggregated 13F filings for Q2 2017.